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Abstract
Findings: To facilitate automation, a novel DNA extraction method for MRSA was adopted. The MRSA specific
chromosome-SCCmec PCR was adapted, additional primers were added, and the performance was validated. From
various laboratories in The Netherlands we received a total of 86 MRSA clinical isolates, that were negative in
commercially available tests. We identified 14 MRSA strains with new variant chromosome-SCCmec junctions by
sequence analysis. These MRSA strains appeared to carry SCCmec sequences with a high degree of homology to
SCC regions of S. epidermidis and S. haemolyticus. All were included for detection in chromosome-SCCmec based
PCR.
Background: Efficient management of Methicillin Resistant Staphylococcus aureus (MRSA) in the hospital is needed
to prevent dissemination. It is important that MRSA can be rapidly identified, and effective infection control
measures can be initiated. Equally important is a rapid MRSA negative report, especially for patients in isolation.
For negative screening we implemented fully automated high through-put molecular screening for MRSA.
Conclusions: Fourteen variant chromosome-SCCmec junctions in MRSA, that are not detected in commercially
available MRSA detection kits were added to our PCR to detect all currently known variant SCC-mec types of MRSA.
Background
The dissemination of Methicillin Resistant Staphylococcus
aureus (MRSA) in hospitals is a growing problem world-
wide. In The Netherlands, a search and destroy policy is
implemented [1]. Patients colonized with MRSA are kept
in isolation until they are culture negative. A MRSA nega-
tive report can faster be obtained by PCR. Therefore, a
molecular approach for negative screening of MRSA was
exploited. Molecular detection of the mecA gene, which
confers resistance to all b-lactams, has often been used in
combination with other S. aureus specific genes in a multi-
plex PCR. Genes that are specific for S. aureus comprise
for example of the sequence published by Martineau et al.
[2], the nuclease gene (nuc) [3,4], or the coagulase gene
(coa) [5]. When clinical samples contain a mixture of coa-
gulase negative staphylococci (CNS), methicillin sensitive
S. aureus (MSSA), and MRSA, a positive mecA PCR can
be generated by CNS while both MSSA and MRSA gener-
ate a positive PCR for the coa or the nuc gene. Only
culturing could confirm MRSA. Another approach for
detection of MRSA was presented by a multiplex PCR
described by Huletsky et al. [6]. This PCR specifically tar-
gets the junction between a conserved open reading frame
orfX in S. aureus, and the staphylococcal cassette chromo-
some containing the mecA gene (SCCmec). For MRSA, 8
different types of SCCmec elements have been classified
[7]. The SCC is known to be a mobile heterogeneous
genetic element that integrates site specifically into orfX.
SCCmec is an SCC containing the mecA gene. SCC can
also be present in CNS, not containing mecA but
integrated into the analogous chromosomal location.
MSSA can contain non-mecA-SCC or SCCmec elements
which have lost the region containing mecA. Several com-
mercially available molecular screening tests are based on
PCR amplification of the chromosome-SCCmec junction.
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In this study, a novel DNA extraction method for
MRSA was adopted that virtually prevents PCR inhibi-
tion. The detection process was fully automated for high
through-put of clinical materials. An extra 17 forward
primers were added to PCR to detect several newly
identified MRSA strains in this study carrying SCCmec
variants and found to be present in The Netherlands,
and possibly elsewhere. An adaptable PCR format is
needed for reliable detection of all MRSA.
Findings
Implementation and evaluation of orfX/SCCmec PCR
The PCR as described by Huletsky et al. [6], was slightly
adapted (Table 1).
To allow PCR detection of more MRSA types, a litera-
ture search was conducted. Forward primer F7 was
derived from the sequence of S. aureus strain JCSC
3624 (WIS), accession number AB121219 [8], and was
included in the PCR. Primer F10 was designed based on
the sequence of S. aureus U10927 [9] (Table 1).
With the expanded orfX/SCCmec PCR a total of 1906
samples was investigated with high through-put screen-
ing; 303 were PCR positive, no inhibition of PCR was
found. To verify whether a positive signal was due to
viable or dead MRSA, all were cultured; 141 were
culture positive, and 22% of 141 were found to be
MSSA. The latter may have lost mecA regions or con-
tain non-mecA SCC elements. All culture positive
MRSA were confirmed by mecA/coa PCR. Thus, PCR is
highly non specific. However, since all suspect samples
are subsequently cultured, this is acceptable. With nega-
tive screening it is important that the negative predictive
value is 100%.
One MRSA isolate found by routine culture was nega-
tive in PCR. We analyzed the sequence of this strain
(303480, Table 2) by genomic DNA sequencing with
primer R1. A sequence of 345 bp was obtained which
was aligned to Genbank/EMBL DNA sequences using
BLAST. No significant sequence homology was found
except that the 35 bp flanking orfX showed 97%
Table 1 Primer and probe sequences used in OrfX-SCC PCR
primer/probe Sequence 5’-3’ Reference
F1 GTCAAAAATCATGAACCTCATTACTTATG according to Huletsky et al.
F2 AATATTTCATATATGTAATTCCTCCACATCTC adapted from Huletsky et al.
F3 CTTCAAATATTATCTCGTAATTTACCTTGTTC adapted from Huletsky et al.
F4 CTCTGCTTTATATTATAAAATTACGGCTG according to Huletsky et al.
F5 TCACTTTTTATTCTTCAAAGATTTGAGC adapted from Huletsky et al.
F7 CCATTTCTTCCAAAAAATATATTTACTTTAGTC This study
F8 TTTCATAATATGTGCTACGCAACCTA This study
F9 CGAGTTAATTTTTTATTTTAGAGCGCTTAC This study
F10 CCGCTCCTTTTATATTATACACAACCTATT This study
F11 GCCATATTAATGCCTCACGAAAC This study
F12 CATTCATTAACATCGTACTCTGCATTT This study
F13 TCCCTTTATGAAGCGGCTGAA This study
F14 AAGCTATAGTTCAGCATTATCGTAAGTTAACT This study
F15 TGCCAATCACAGTTCAATCAATTATT This study
F16 TCCTTTCTAATTATATTATGCGCAACCT This study
F17 ACTCTGATAAGCCATTCATTCATCCA This study
F18 ACAATCCTAACATAAGATTGTGGCTTT This study
F20 GCATATTCACTTTGATAAGCCATTCAT This study
F21 CGGTTCTGATATCTTTTCAACCATT This study
F23 CCCCTCCCATTAACTCCGTATAT This study
F24 CCCAAACTCTTAACTTTCTTCAATACATT This study
F25 TTCTAAGGTAGCTTCCCTTTCAATAATTT This study
R1 CGTCATTGGCGGATCAAAC adapted from Huletsky et al.
R2 CGTCATTGGTGGATCAAACG adapted from Huletsky et al.
probe2 FAM-CACAAGGATGTCTTACAACG-MGB adapted from Huletsky et al.
probe3 FAM-CACAAGGACGTCTTACAACG-MGB adapted from Huletsky et al.
probe4 FAM-CACAAAGACGTCTTACAACG-MGB adapted from Huletsky et al.
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homology with a repeated sequence found in S. haemolyti-
cus (AP006716;bp 52313, and 91034), also present in S.
saprophyticus (AP08934;bp 50105). A new primer in PCR
(primer F8, Table 1) was derived from the obtained
sequence. To minimize the chance for more false-negative
PCR results for MRSA, other laboratories in The Nether-
lands were asked for MRSA strains that were negative in
commercial molecular tests used by these laboratories. We
received a total of 86 clinical isolates or DNA. Whenever a
strain was also negative in our orfX/SCCmec PCR, DNA
was sequenced and a new primer was added to PCR. Of
86 strains, another 14 additional forward primers were
designed, apart from 2 literature based primers, and 1
primer based on a MRSA strain from our own hospital.
All 17 primers were included in PCR to a total of 22
forward primers (Table 1).
Sequence analysis of PCR negative MRSA strains
All 14 strains mentioned above were verified to be MRSA
using mecA/coa PCR. All were positive in both PCRs.
The results of DNA sequence analysis are presented in
Table 2. BLAST comparisons were made with the
sequences cut off at the orfX according to Ito et al. [10].
Within the orfX gene, the obtained sequences were highly
homologous and consistently aligned to S. aureus orfX.
The SCCmec of 5 strains showed various degrees of
homology (91-100%) with different parts of SCCmec
sequences of S. aureus strains. Two MRSA strains
showed 99% homology with S. epidermidis SCC, but
with different regions. Another 3 strains were homolo-
gous to S. haemolyticus in their orfX flanking sequences.
BLAST alignments of strains 303480 and 251110219
showed no significant sequence homologies except for a
35 bp repeat (CAACtTATTTTTTAGTTTTATTTGT-
GATACGCTTCT)found present in S. haemolyticus and
S. saprophyticus. The orfX flanking regions of 3 other
strains showed no significant homology to any
Genbank/EMBL sequences.
Comparison of right SSCmec-OrfX junctions
The alignment of right SCCmec-OrfX junctions is shown
in Figure 1. The direct repeat consensus (–A-TT-
TGATA-GC-TC, [10]) is largely intact, suggesting that
SCC sequences from S. epidermidis and S. haemolyticus
were acquired by recombination rather than by
transposition.
Discussion
The staphylococcal cassette chromosome SCCmec is a
genetic mobile element that contains the methicillin
resistant mecA gene [8]. Its site-specific insertion or
excision is mediated by cassette chromosome recombi-
nase (ccr) complex and by the presence of direct and
inverted repeats at the SCCmec extremities. The
combination of classes of mec gene complex and ccr
gene complex forms the basis of their classification
[10]. At present 8 types of SCCmec elements have
been classified [7,11]. In addition, SCCmec can harbour
other drug resistant genes, and insertion sequence ele-
ments (IS431, IS1272), transposons (Tn4001, Tn554)
or plasmids (pUB110, pT181). The chromosome flank-
ing regions (junction or J-regions, formerly, junkyard
regions) of SCCmec are most variable in their DNA
sequences.
Table 2 Observed sequence homologies of analyzed MRSA strains from various locations, length of DNA sequence
analysis reads, and PCR primers based on these sequences
Strain Location bp Homology (%) with accession number (species) corresponding to bp primer
02M023064 Breda 222 94% U10927 (S. aureus);bp 648-426 F9
JBZ12 Den Bosch 235 93% AB539727 (S. aureus);bp 84645-84507 F13
261207168 Enschede 834 91% AB063172 (S. aureus); bp 169-879 F15
JBZ33 Den Bosch 396 99% EU272080 (S. aureus);bp 794-399 F23
S0121 Utrecht 280 100% EU263618 (S. aureus);bp 655-376 F17
CC8 Denmark ( ) 422 99% BK001539 (S. epidermidis);bp 19437-19016 F20
434-1819 Eindhoven 416 99% BK001539 (S. epidermidis);bp 34917-34205 F24
S0089 Utrecht 409 100% AP006716 (S. haemolyticus);bp 52718-52358 F16
582 Utrecht 344 98% AP006716 (S. haemolyticus);bp 91374-91031 F18
060120 Leiden 912 98% AP006716 (S. haemolyticus);bp 30663-29755 F25
303480 Rotterdam 345 CGCAACCTATTTTTTAGTTTTATTTGTGATAtGCT F8
251110219 Enschede 900 CAACtTATTTTTTAGTTTTATTTGTGATACGCTTCT F14
JBZ54 Den Bosch 688 No significant homology found F21
40295861 Breda 417 No significant homology found F11
40461611 Breda 762 No significant homology found F12
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We adapted the PCR described by Huletsky et al. [6],
based on amplification of the chromosome-SCCmec
junction. We initially included 2 more forward primers
to expand detection to MRSA known from literature.
After sequence analysis of 14 MRSA strains that were
not recognized by the initial primer set, we included
additional primers resulting in a megaplex PCR with 14
primers based on sequences of newly identified MRSA
with variant SCCmec sequences to a total of 21 forward
primers. No adverse effects on PCR were seen with this
number of primers.
From 3 strains the sequenced SCCmec region did not
match any known DNA sequence, presuming a non-
human relation. In The Netherlands live-stock asso-
ciated MRSA is increasingly isolated [12]. Reischl et al.
[13] have shown that live-stock associated MRSA can be
discriminated on the basis of a G®A mutation in orfX.
Based on the finding that these strains were only posi-
tive in PCR when the probe harbouring this mutation
(probe 2) was used, we confirmed that these 3 strains
were most probably live-stock associated MRSA.
In the SCCmec of the other new strains, repeated
sequences as IS431 and IS1272 were found. IS elements
are mobile and can move by transposition. The similar
but not identical repeats found in strain 303480 and
251110219, might be related to an IS1272 encoded trun-
cated transposase as was indicated by BLAST homology.
This suggested that the variant SCCmec sequences
resulted from transposition. Therefore the right chromo-
some-SCCmec junctions carried by the new MRSA
strains were compared. The consensus represented the
direct repeat (DR) involved in insertion and excision of
SCCmec. Consequently, the variant SCCmec sequences
were acquired by recombination rather than transposi-
tion. Mongkolrattanothai et al. [14], reported a non-
mecA-SCC element present in S. epidermidis with 3 DR
highly homologous to S. aureus, 2 at the extremities of
the element and 1 in the middle. The 2 MRSA strains
carrying different SCC homologs of S. epidermidis in
this study, were each highly homologous to the SCC
described by Mongkolrattanothai [14], but represented
the sequence on either side of the middle DR. This find-
ing may corroborate the recombination theory, regard-
less of the orientation of the inserted SCC in the 2
MRSA strains. Whether mecA is carried on the acquired
SCC from S. epidermidis of the MRSA strains found in
our study, as well as SCC typing, remains a topic for
future studies.
In conclusion, it appears that MSSA can convert to
MRSA by acceptance of SCC sequences from CNS. This
process may be driven by selection pressure of antibio-
tics. Indeed, an isogenic pair of MSSA and MRSA was
recently described that supports the occurrence of
horizontal transfer of SCCmec between Staphylococcal
species [15]. The 86 strains not detected as being MRSA
in other laboratories by commercially available tests
raises concern about their performance [16,17]. Exploit-
ing the SCCmec junction as target in PCR used for
detection of MRSA requires continuous awareness of
possible variants. PCR based on mecA/nuc gene does
Figure 1 Alignment of right SCC-OrfX junctions. Strains are designated by the primers based on their sequences. OrfX starts at bp 55
(according to Ito et al. [10]. SA; S. aureus, SE; S. epidermidis, SH; S. haemolyticus, SR; Staphylococcal repeats. Strains without any homology to
known sequences were omitted from the comparison.
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not seem to present an acceptable alternative because
the nuc gene may be absent as has been found earlier
[18]. The mecA/coa PCR, combined with chromosome-
SCCmec junction PCR identifies other MRSA variants
that may arise.
Conclusions
We identified 14 new variant chromosome-SCCmec
junctions in MRSA, that are not detected in commer-
cially available MRSA detection kits. We adapted our
PCR to detect all known variant chromosome-SCC-mec
types of MRSA.
Fully automated high through-put detection and
robust DNA extraction support an adaptable PCR for-
mat for detection of these newly identified MRSA
strains. Moreover, this system can easily be expanded
with novel PCR primers when new variants of chromo-
some-SCCmec types in MRSA may arise.
Methods
Clinical samples
Samples were taken from nose, throat, and perineum,
and if appropriate also from wounds, sputum, and
catheters (Transwab, Medical Wire & Equipment Co.
Ltd., Corsham, Wilts., England) in the context of
patient and personnel screening as required by the
Dutch policy for MRSA control. Since no extra action
or sampling was requested than the medically indi-
cated, informed consent was not asked and no ethical
approval was required, in conformity to the guidelines
of the Dutch Central Committee on Research involving
Human Subjects. Swabs were inoculated into 5 ml
phenyl mannitol broth (PHMB) containing ceftizoxime
and aztreonam [19] for overnight incubation. After at
least 18 hours of incubation, PHMB broth was
subjected to PCR.
Automated DNA isolation, PCR detection, and data
output by MRSA-screen with PCR amplification
of OrfX-SCCmec junction
PHMB tubes were placed into the MultiPROBE II PLUS
HT Expanded pipetting robot (PerkinElmer Life and
Analytical Sciences). This system is equipped with a
bar-code reader and automated plate sealer (RoboSeal).
This system handles the DNA extraction, PCR assay set-
up, and sealing of the plate. Next, the plates are automa-
tically transferred to a real-time ABI 7900HT thermocy-
cler (Applied Biosystems, Nieuwerkerk a/d IJssel, The
Netherlands). Thus, barcode scanning, DNA extraction,
pipetting, sealing of the 384-well PCR Plate, creating a
run file and starting the PCR, were done by the system
without interference or need of presence of a technician.
Results were automatically transferred to the Laboratory
Information System.
Software was programmed by PerkinElmer to perform
the following steps. After barcode reading, 5 ml of saline
was added and mixed by pipetting. This 1:1 dilution
served to elevate the fluid level and to prevent the 9.5
cm long probes touching the swabs in the 15 cm long
tubes.
Template DNA was prepared by using the Extract-N-
Amp™ Plant PCR Kit (SIGMA, Munich, Germany). In
short, 50 μl sample was mixed with 100 μl SIGMA
Extraction Solution (E7526). The mixture was incubated
at 95 °C for 10 minutes, cooled to room temperature,
100 μl SIGMA Dilution Buffer (D5688) was added and
mixed. This DNA sample is PCR ready when used in
combination with the SIGMA Extract-N-Amp PCR
ReadyMix™ (E3004).
Primers and probes for detection of the OrfX-SCCmec
junction were used in one primer-probe mixture with
the following concentrations; 600 nM for each F and R
primer, and 120 nM for each probe (Table 1). Each
sample was tested with this primer-probe mixture.
Amplification reactions were performed in a volume of
20 μl, with 10 μl SIGMA Extract-N-Amp PCR Reaction
Mix™ (including 4% Reference Dye) in 6 μl primer-
probe mix and 4 μl of the DNA sample. Amplification
consisted of 3 min at 95 °C followed by 44 cycles of 15
s at 95 °C and 60 s at 60 °C. In each run a MRSA posi-
tive and a negative control was included. A sample was
regarded suspect for MRSA in the MRSA-screen if the
PCR was positive. Positive samples were subsequently
cultured on blood agar plates.
MecA/coa gene PCR
The mecA PCR was carried out as described [4], with
800nM of each primer. PCR for coa was as described
previously [5]. The concentration of primers Coag2:
CGAGACCAAGATTCAACAAG, and Coag3: AAA-
GAAAACCACTCACATCA was 800nM each. MecA/coa
PCR was used to confirm MRSA isolates. Results of
mecA and coa PCR were analyzed using agarose gel
electrophoresis.
DNA sequence analysis
Sequence analysis was performed by Baseclear, Leiden,
The Netherlands on total chromosomal DNA with
primer R1 (Table 1). Partial sequences of variant SCCmec
have not yet been submitted but will be classified in
further studies according to the recommendations of the
International working group on the classification of
staphylococcal cassette chromosome elements [11].
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